Renaissance Technologies (RenTech)'s TLSA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 13,100 shares of Tiziana Life Sciences Ltd (TLSA) worth $16,768, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TLSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 78,267 shares. Largest reduction occurred in Q1 2021, reducing 155,100 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Tiziana Life Sciences (TLSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tiziana Life Sciences (TLSA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +13,100 | New Buy | 13,100 | $1.28 |
| Q1 2022 | -78,267 | Sold Out | 0 | $0.00 |
| Q4 2021 | +78,267 | New Buy | 78,267 | $0.96 |
| Q3 2021 | -32,670 | Sold Out | 0 | $0.00 |
| Q2 2021 | +8,596 | Add 35.71% | 32,670 | $4.68 |
| Q1 2021 | -155,100 | Reduce 86.56% | 24,074 | $5.52 |
| Q4 2020 | +66,850 | Add 59.52% | 179,174 | $4.04 |
| Q3 2020 | -79,801 | Reduce 41.54% | 112,324 | $6.66 |
| Q2 2020 | +192,125 | New Buy | 192,125 | $5.14 |
Renaissance Technologies (RenTech)'s Tiziana Life Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Tiziana Life Sciences Ltd (TLSA) in Q2 2020, acquiring 192,125 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Tiziana Life Sciences Ltd (TLSA) for 9 quarters since Q2 2020.
Renaissance Technologies (RenTech)'s largest addition to Tiziana Life Sciences Ltd (TLSA) was in Q2 2020, adding 192,125 shares worth $987,000.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 13,100 shares of Tiziana Life Sciences Ltd (TLSA), valued at approximately $16,768.
As of the Q2 2026 filing, Tiziana Life Sciences Ltd (TLSA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Tiziana Life Sciences Ltd (TLSA) was 192,125 shares, as reported at the end of Q2 2020.